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The ability of guinea pigs to recognize poly-I,-lysine (PLL), and hapten conjugates 
of PLL (H-PLL) as antigens is under the control of a single autosomal dominant gene 
which we will refer to as the PLL gene (1-3). Responder animals carrying this gene 
form  specific  antihapten  antibodies  and  display  delayed  hypersensitivity  reactions 
after  immunization  with H-PLL conjugates such as  2,4-dinitrophenyl-PLL  (DNP- 
PLL); guinea pigs lacking  the  PLL gene  are  incapable  of an  immune  response  to 
DNP-PLL but can nevertheless recognize this conjugate as a hapten. Thus, immuni- 
zation with DNP-PLL complexed with a  negatively charged foreign albumin  elicits 
the  formation of high levels  of anti-DNP-PLL  antibodies  in genetic nonresponder 
guinea pigs (4).  Two interesting observations were made concerning the response of 
these  guinea pigs:  (a)  only an  antigenic foreign albumin  could act as a  carrier  for 
DNP-PLL and  stimulate  the production of high concentrations of anti-DNP-PLL 
antibodies  in guinea pigs lacking the PLL gene; guinea pig albumin was only mar- 
ginally effective in this capacity; and  (b)  nonresponder guinea pigs immunized with 
DNP-PLL complexed with ovalbumin or bovine serum albumin did not show delayed 
hypersensitivity reactions  to DNP-PLL in spite of the production of high levels of 
anti-DNP-PLL antibodies. This finding demonstrates the haptenic behavior of DNP- 
PLL in nonresponder guinea pigs  as it has  been well  established  that  haptens  are 
incapable of eliciting  delayed hypersensitivity reactions  (5-10). 
The process controlled by the PLL gene in the immune response to hapten- 
PLL  conjugates  is  unknown.  Knowledge  of  the  mechanism  which  allows 
an immunogenic carrier to elicit an immune response in a genetic nonresponder 
to the DNP-PLL hapten which it bears should eventually lead to a more com- 
plete  understanding  of  the  requirements  for  antigenicity  and  should  also 
clarify the function of the PLL gene product.  This  system offers several  dis- 
tinct  advantages  over  other,  more  complex,  antigenic  systems  because  first, 
the  hapten  PLL conjugate can behave  either  as  a  complete  antigen  or  as  a 
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hapten  (4);  second,  the  specificities  of  the  antibodies  directed  against  the 
hapten and carrier can be more precisely analyzed; and third, the electrostatic 
interaction between  the  hapten  and  carrier would be  expected  to  produce  a 
minimal  amount  of  distortion of  the  carrier molecule.  A  further  analysis of 
the hapten-protein carrier relationship in nonresponder guinea pigs immunized 
with  DNP-PLL  complexed with  foreign albumins  was  therefore undertaken. 
To  study  in  more  detail  the  requirement  for  an  antigenic  carrier molecule, 
the effect of inducing tolerance to the foreign albumin used to form electrostatic 
complexes with DNP-PLL on the ability of these complexes to elicit the forma- 
tion  of anti-DNP-PLL  antibodies by nonresponder  guinea pigs  was  investi- 
gated.  In  addition,  the  ability of  DNP-PLL  to  specifically stimulate  DNA 
synthesis in vitro by lymph node cells from responder and nonresponder ani- 
mals immunized with DNP-PLL  or with DNP-PLL. albumin complexes was 
examined in order to correlate the presence of delayed hypersensitivity reactions 
to DNP-PLL  with  the capacity of the lymphoid cells of these animals  to be 
stimulated by DNP-PLL. 
Material and Methods 
Polypeptides and  Proteins.--Poly-L-lysine  (PLL)  hydrebromide with average molecular 
weight of 90,000, and a copolymer of L-glutamic acid and L-lysine (GL) with a molecular weight 
of 110,000 were obtained from Pilot Chemical Co., Watertown, Mass. Bovine serum albumin 
(BSA) was purchased from Armour Pharmaceutical Co., Chicago, Ill. Five times recrystal- 
lized hen ovalbumin (OVA) was obtained from Pentex, Inc., Kankakee, Ill. Guinea pig albumin 
(GPA) was prepared by electrophoresis on starch block of guinea pig serum (11). 
Other Reagents.--Fretmd's  complete adjuvant was obtained from Difco Laboratories, Inc., 
Detroit,  Mich.  1-fluoro-2,4-dinitrobenzene  (DNFB)  was  obtained from  Eastman  Organic 
Chemicals, Rochester,  N.Y. 3H-thymidine was purchased from New England Nuclear Corp., 
Boston, Mass. Eagles' Minimal Essential Medium (MEM) was obtained from Grand Island 
Biological Company, Grand Island, N.Y. 
Preparation of Conjugates.--DNP-PLL  and DNP-GL were prepared by the reaction of PLL 
or of GL with DNFB in p-dioxane under alkaline conditions as previously described (1). Poly- 
peptide concentrations were determined by micro-Kjeldahl  nitrogen measurements. The degree 
of DNP substitution was calculated from the absorbancy at 360 m/~ on the basis of the molar 
extinction coefficient of free ~-DNP-L-lysine (~ =  17,400) (12). A single DNP20PLL431 conju- 
gate was used for this study. The subscripts refer respectively  to the average number of groups 
of hapten and the average number of lysyl  residues in the molecule. 
Preparation of DNP-PLL.Albumin Complexes.--OVA  or BSA (at concentration of 5 mg/ml 
in 0.075 ~  NaC1) was added to an equal volume of a solution of 5 mg/ml of DNP-PLL in 
0.075 M  NaC1. 0.1 N NaOH was added dropwise until a precipitate  formed. 
Basic Immunization  Procedure.--Hartley  guinea pigs weighing 300-400 g were purchased 
from Carom Research Laboratories, Wayne, N.J. The animals were immunized  in the four 
foot-pads with 0.1 mg of DNP-PLL in 0.4 mi of emulsion containing equal volumes of the anti- 
gen and of complete Fretmd's adjuvant. Booster injections of 10/zg of DNP-PLL were given 
intradermaily at 7-8 days. When DNP-PLL.albumin complexes were used to immunize ani- 
mals, 0.2 mg of the complexes in 0.4 ml of emulsion containing  equal volumes of the antigen 
in saline and complete Freund's adjuvant was given in the four foot-pads. 
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delayed hypersensitivity reactions to DNP-PLL was evaluated 24 Jar after intrsdermal injec- 
tion of 10/~g of DNP-PLL in 0.I ml of 0.15 hTaCl. The presence of serum antibodies against 
DNP-PLL, BSA, or OVA was revealed by double diffusion analysis in agar gel against DNP4x 
GPA,  BSA,  or  OVA at  a  concentration  of 0.25  mg/ml, To detect low levels of anti-DNP 
antibodies,  equilibrium dialysis of the globulin fraction of serum against  8H-DNP-e-amino 
caproic acid was  performed as previously described  (4).  To detect  low levels of anti-BSA 
antibodies,  passive hemagglutination of BSA-tanned sheep erythrocytes was performed ac- 
cording to the method of Stavitsky (13). 
Production of Tolerance to BSA.----40 guinea pigs were rendered  tolerant  to BSA by the 
method of Salvia (14). They were given 10 nag of cyclophosphamide intraperitoneally  daily 
for 8 days. On the 3rd day of the cyclophosphamide administration, the animals were injected 
intraperitoneaily with 50 nag of sterile bovine serum albumin. 40 days after this procedure, 
the 11 surviving animals (group I) were immunized with 0.2 nag of DNP-PLL-BSA incorpo- 
rated in complete Freund's adjuvant. At the same time, a group of untreated animals (group 
II)  were immunized with DNP-PLL. BSA in an identical fashion. 10 days after immunization 
all animals were boosted with 10/~g of DNP-PLL and with 100/~g of DNP-PLL.BSA com- 
plex. Genetic responder animals were identified as those displaying delayed hypersensitivity 
reactions to DNP-PLL (4). The animals were bled on the 18-20th day after immunization. 
~Stimulation of DNA Synthesis of Sensitized Lymph Node Cells  in Vitro.--The effect of DNP- 
PLL and  DNP-PLL complexed to OVA or BSA on the incorporation of SH-thymidine into 
DNA by lymph node ceils from individual responder and nonresponder guinea pigs immunized 
with DNP-PLL or DNP-PLL complexed to OVA or to BSA was investigated. Animals were 
immunized as described under basic immunization procedures. 
A detailed description of the tissue culture methods and of the extraction of the DNA is 
given in a companion paper  (15) and therefore only a brief outline of the method will be de- 
scribed now. Sterile technique was used throughout. Lymph node ceils were obtained from the 
peripheral lymph nodes of guinea pigs by teasing the nodes in MEM containing 15% pooled 
normal guinea pig serum and penicillin. 10 X  10  s cells, suspended in the same medium, were 
placed in 12 X  75 mm plastic culture tubes (Falcon Plastics, Los Angeles, Calif.)  and antigen 
was added. Total volume per tube was 1.5 ml. The cultures were incubated for 24 hr at 37°C 
in an atmosphere of 5% CO2-95%  air.  1/~c (2 pg) of *H-thymidine was then added and the 
cultures incubated for an additional 24 hr. The DNA was then extracted from the ceils and 
hydrolyzed. The radioactivity was measured in a Packard Tri-Carb liquid scintillation counter. 
Tubes were set up in duplicate, triplicate, or quadruplicate. The concentrations of test anti- 
gens added  to the cultures are expressed  as micrograms per milliliter and are  shown  in  the 
respective tables. The results are expressed  as the quotient of the ratio: 
Counts in tubes with a given antigen concentration 
Counts in tubes with no antigen 
A value of this ratio greater than one indicates stimulation of DNA synthesis. 
RESULTS 
Effect of Tolerance to  BSA  on  the  Immune Response to  DNP-PLL. BSA  in 
Guinea Pigs Lacking  the PLL Gene.--AU normal  guinea  pigs  immunized  with 
DNP-PLL.BSA  made  anti-DNP  antibodies,  as  shown  by  both  gel  diffusion 
analysis  against  DNP-GPA  and  equilibrium  dialysis  using  SILDNP-EACA. 
The nonresponder  animals  were identified as those not demonstrating  delayed 
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produced anti-BSA antibodies, as demonstrated by gel diffusion analysis and 
by passive hemagglutination using BSA-coated sheep red blood cells (Table I, 
group II). 
The 11 guinea pigs in which tolerance to BSA was induced were in excellent 
condition 40  days later when they were immunized with I)NP-PLL. BSA in 
TABLE I 
Production  of Anti-BSA  Antibodies  and Anti-DNP-PLL Antibodies  in Genetic Nonresponder 
Guinea  Pigs Rendered  Tolerant  to BSA  and  Immunized  with DNP-PLL. BSA 
Animals 
Group I 
Tolerant 
animals 
1 
2 
3 
4 
S 
6 
7 
8 
9 
Group II 
12 control ani- 
mals 
Group III 
41 control ani- 
mals 
Immunizing 
antigens 
DNP-PLL.BSA 
DNP-PLL'BSA 
Complete adjuvant 
alone 
Anti-BSA  antibodies 
Gel diffusion 
+ 
+ 
+ 
(all  12 animals) 
Passive 
hemagglutin- 
atlon 
<1/2o 
*£1/20 
<1/2o 
<1/20 
<1/2o 
1/20 
1/40 
1/40 
1/640 
1/160 to 1/1280 
Anti-DNP-PLL  Antibodies 
Gel diffusion* 
m 
+ 
+ 
+ 
(all  12 animals) 
Equilibrium 
dialysis~; 
( nu~ hapten 
bound/ml 
serum) X  101° 
422 
158 
374 
135 
1308 
750 
1500 
1805 
6960 
Mean 5900 
Range 2900- 
82OO 
Mean  240  :t= 
205 
*  With DNP-GPA  0.25  mg/ml. 
:~  Equilibrium dialysis  performed with 3H-DNP-EACA  at an initial  concentration  of 2 X  I0  -z ~. 2.5 ~g of 
antibody can  bind 1000 X  10  -m mm hapten when both sites  are  occupied, considering the tool  wt for  guinea pig 
antibodies to be 150,000. 
complete adjuvant. Complete or partial tolerance to BSA was demonstrated in 
these animals. Two of these BSA-tolerant animals proved to have the PLL gene, 
as shown by their ability to  develop delayed hypersensitivity to  DNP-PLL. 
As expected, these two responder guinea pigs made normal amounts of anti- 
DNP-PLL antibodies, but no anti-BSA antibodies, indicating that the general 
ability of the animals to respond to antigens other than BSA, to which they had 
been made specifically tolerant,  had not been affected by the treatment with 
cyclophosphamide. 
The remaining nine animals in this group (group I) were genetic nonresponder 
guinea pigs; three of these nine guined pigs made significant amounts of anti- GREEN,  PAUL,  AND  BENACERRAF  47 
DNP-PLL antibodies, but less than is usually observed in nontolerant control 
animals. These same animals produced small amounts of anti-BSA antibodies, 
indicating that complete tolerance to the carrier albumin had not been achieved. 
The  remaining six  animals  produced  trace  or  undeteetable  amounts  of both 
TABLE  II 
Effect of Antigen on the In Vitro Incorporation of 8H-Thymidine  into DNA by Lymph Node Cells 
from Genetic Responder Guinea Pigs Immunized with DNP-PLL, DNP-PLL.  BSA, 
or DNP-GL 
Animal 
No. 
1" 
2 
3 
4 
5 
9 
10 
11 
12 
Immunizing antigen 
Adjuvant +  saline 
Adjuvant +  saline 
Adjuvant +  saline 
Adjuvant +  saline 
Adjuvant  +  saline 
DNP-PLL 
DNP-PLL 
DNP-PLL 
DNP-PLL-  BSA 
DNP-PLL-  BSA 
DNP-GL 
DNP-GL 
No. days 
after 
immunization 
10 
14 
14 
19 
19 
75 
75 
85 
15 
15 
13 
19 
Test antigens 
DNP-PLL 
10/~g/ml 
1.39~ 
0.99 
1.8 
1.15 
O.7O 
7.7 
10.5 
4.78 
6.6 
DNP-GL 
100 /..tg/ml 
6.78 
7.65 
)NP-PLL 
1  /zg/~fl 
0.97 
1.22 
1.04 
3.2 
4.5 
20.9 
1.75 
4.4 
DNP-GL  i 
i  /~g/ml 
5.64 
7.30 
DNP-PLL 
-BSA 
I p~,/ml 
6.84 
6.84 
DNP-GL 
D.01 /ag/ml 
2.56 
3.72 
BSA 
1 #tg/ml 
1.6 
1.56 
*  Animals 1-5 are control guinea  ags of unknown  status with regard to the PLL  gene. 
Animals 6--12  are  genetic  responder  guinea  pigs. 
:~  Relative incorporation of  3H-thymidine into  DNA  obtained from: Counts in DNA  from 
cultures  with antigen/Counts in DNA  from cultures  without antigen. Values  > i indicate 
stimulation of  DNA  synthesis. 
anti-BSA  and  anti-DNP  antibodies.  Thus,  in  BSA-tolerant  genetic  non- 
responder guinea pigs immunized with DNP-PLL. BSA a  correlation between 
their inability to make anti-BSA antibodies and their inability to make anti- 
DNP-PLL antibodies was demonstrated. This experiment illustrates that when 
complete tolerance to the carrier albumin is established,  this molecule can no 
longer induce antibody synthesis against oppositely charged haptens complexed 
with it. 
Stimulation by DNP-PLL of DNA Synthesis by Specifically Sentisitized Lymph 
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node cells from guinea pigs immunized with adjuvant alone, with DNP-PLL, 
with DNP-GL  alone,  with DNP-PLL.0VA,  or with DNP-PLL.BSA  was 
investigated.  The response  of cells  from control  animals  immunized only  with 
adjuvant and from genetic  responder animals  immunized with DNP-PLL, 
TABLE III 
Effect of Antigen on the In Vitro Incorporation of att-Tkymidine into DNA by Lymph Node Cdls 
of Genetic Nonresponder  Animals  Immunized  with  DNP-PLL,  DNP-PLL.BSA, 
DNP-PLL.OVA, or DNP-GL 
Animal  no. 
7 
8 
9 
10 
11 
12 
13 
14 
15 
Immunizing  antigen 
DNP-PLL 
DNP-PLL 
DNP-PLL 
DNP-PLL 
DNP-PLL. BSA 
DNP-PLL- BSA 
DNP-PLL-  OVA 
DNP-PLL"  OVA 
DNP-PLL"  OVA 
DNP-PLL.  OVA 
DNP-PLL.  OVA 
DNP-PLL.  OVA 
DNP-PLL.  OVA 
DNP-PLL. 
No. days  BSA or  after im-  DNP-PLL  DNP-PLL  Ova 
munlzation  I0 l.Lg/ml  ! ~g/ml  DNP-PLL.ovA !/~g/ml 
2/Jg/ml 
15  0.91"  .87 
15  0,56  1.05 
14  0.98  0.77 
14  0,40  1.4 
DNP-GL 
DNP-GL 
22  1.26  7.2 
22  1.22 
15  1.47  1.15  6.8  3.0 
15  0.57  1.06  10,2  2.6 
21  0.35  1.41  3,7  5.0 
21  0.44  1.7  4.2  2.3 
11  0.76  1.86  1.94 
11  0.54  4.73  4.40 
11  0.70  2.12  1.76 
DNP-GL  DNP-GL  DNP-GL 
i0 ~g/ml  1/~g/ml  0.01 ~g/ml 
13  1.09  1.20  1.37 
19  1.17  1.11  0.50 
* Relative incorporation of 3H-thymidine into DNA obtained from: Counts in DNA from 
cultures with antigen/Counts in  DNA from cultures without  antigen. Values  > 1 indicate 
stimulation of DNA synthesis. 
DNP-GL, or DNP-PLL. BSA is presented in Table II. The results are expressed 
as the amount of SH-thymidine  incorporation into DNA by cell cultures exposed 
to a  given antigen concentration divided by the incorporation of ~-I-thymidine 
into DNA by cultures derived from the  same guinea pig but not  exposed  to 
antigen. A  value greater than 1.0 for this ratio is evidence of  stimulation of 
DNA synthesis by the antigen. DNP-PLL at concentrations of 1 or 10/zg/ml 
did  not  appreciably stimulate DNA  synthesis by  control cell cultures from GREEN, PAUL, AND BENACERRAF  49 
animals immunized with adjuvant alone. The highest value obtained was only 
1.8 and most values were considerably lower. A significant stimulation of DNA 
synthesis by 1 or 10 #g/ml of DNP-PLL was observed with all lymph node cell 
cultures from genetic responder animals immunized with DNP-PLL or DNP- 
PLL. BSA. A similar degree of stimulation was also observed with DNP-GL in 
the case of cells from responder guinea pigs immunized with this antigen. 
In contrast to these responses, lymph node cells from nonresponder  guinea 
pigs which had been immuni~,~ed with DNP-PLL or DNP-GL did not show 
stimulation of DNA synthesis by these antigens in tissue culture (Table  III). 
When cells from nonresponder guinea pigs immunized with DNP-PLL. BSA or 
DNP-PLL. OVA were used, identical results were obtained; DNP-PLL caused 
no stimulation of DNA  synthesis by these  cell populations,  in spite  of  the 
synthesis of anti-DNP-PLL antibodies  by the animals from which these cells 
were derived. However, the lymph node cells from these guinea pigs responded 
typically with increased DNA synthesis to the immunizing complexes, DNP- 
PLL. OVA or DNP-PLL-BSA, or to the carrier albumins  used for immuniza- 
tion, OVA or BSA. No consistent difference could  be observed  between  the 
magnitude of the response of the cells to DNP-PLL. foreign albumin aggregates 
and the response to the albumin alone, although in a few animals the response to 
DNP-PLL-OVA was greater than to OVA. The extent to which such differ- 
ences could be due to the physical state of the two preparations was not deter- 
mined. Thus, a complete correlation was demonstrated in nonresponder guinea 
pigs immunized with DNP-PLL. OVA or DNP-PLL. BSA between the absence 
of delayed hypersensitivity reaction to DNP-PLL and the absence of stimula- 
tion of in vitro DNA synthesis of lymph node cell cultures in response to DNP- 
PLL. 
DISCUSSION 
The results  of these  experiments  confirm the behavior of DNP-PLL as a 
hapten in guinea pigs lacking the PLL gene. Immunization of such animals with 
complexes of DNP-PLL with a foreign albumin induces the synthesis of anti- 
bodies  against DNP-PLL; but  in  spite  of  this  antibody response,  delayed 
hypersensitivity to DNP-PLL cannot be elicited and lymph node cells capable 
of responding in vitro to DNP-PLL with an increase in DNA synthesis are not 
detected. In contrast, delayed hypersensitivity to the foreign carrier albumin is 
observed  and the lymph node cells of these  guinea pigs show an increase in 
incorporation of ~H-thymidine  into DNA  in response  to  the foreign  carrier 
albumin in vitro. 
The  data  presented  also  demonstrate  that  the foreign  albumin must  be 
capable of eliciting an immune response in order to induce antibody formation 
to DNP-PLL complexed with it in animals genetically incapable of responding 
to DNP-PLL alone. Thus, prior establishment of tolerance  to BSA abolished 50  HAPTEN  CARRIER  RELATIONSHIPS 
the production of anti-DNP-PLL antibodies  in these  guinea  pigs. This last 
experiment  is  in  apparent  contradiction with the  observation  that hapten- 
protein immunization of rabbits tolerant to the carrier protein may lead to the 
production of antihapten antibodies (16-19). However, these two situations are 
not completely analogous because it has been shown that the usual covalent 
conjugation procedures alter the protein carrier molecule sufficiently to produce 
new  antigenic  configurations;  such  configurations  may not  necessarily  en- 
compass the hapten (20-23). The simple electrostatic  aggregation of BSA with 
DNP-PLL probably does not modify the structure of the BSA molecule to the 
same  extent as  does covalent conjugation and therefore  such  new  antigenic 
determinants would not be expected to appear. 
How can the findings that tolerance to the carrier albumin renders the animals 
unresponsive  to the hapten which it bears  clarify the nature of the defect in 
genetic  nonresponder  animals  and thereby the process governed by the PLL 
gene? Two general mechanisms for the initiation of the immune response can be 
considered in relationship to the activity of the PLL gene. According to the first 
hypothesis, the ability of specific cells to be stimulated by antigen depends solely 
upon the binding by the cells of antigen; this interaction is a thermodynamically 
driven reaction of antigen with a cell-associated antibody whose specificity is 
identical  with that of the antibody to be produced  by the cell or its progeny. 
With antigen concentrations  achieved under normal conditions  of immuniza- 
tion the binding energy of the antibody for the antigen must be quite high for 
the cells to be stimulated. If this simple interaction is not only necessary but 
also sufficient to stimulate specific cells, the PLL gene would have to be con- 
cerned with the immunological specificity of the ilnmunoglobulins and would 
indeed control  the  capacity of  the  guinea  pig  to  synthesize  molecules with 
structural complementarity  for stretches of lysine residues. 
According to this interpretation nonresponder guinea pigs would be incapable 
of  synthesizing  immunoglobulins  which  can bind DNP-PLL with sufficient 
energy to result in stimulation of sensitive cells but could form immunoglobulins 
which bind DNP-PLL. BSA with an affinity  sufficient to perform this function. 
Tolerance to BSA would be regarded as eliminating those cells whose response 
to DNP-PLL. BSA is dependent upon the partial specificity contributed by the 
portion of the BSA which is postulated to be part of the antigenic determinant 
in DNP-PLL. BSA. The major difficulty with this hypothesis is the failure to 
demonstrate a  significant  degree  of  BSA  specificity  in  the  anti-DNP-PLL 
antibodies  produced  by nonresponder  animals  immunized with DNP-PLL. 
BSA. This lack of BSA specificity was determined by the absence of BSA bind- 
ing by anti-DNP antibodies  purified from the sera  of nonresponder  animals 
immunized with DNP-PLL-BSA,  1 and by the fact that in these animals  the 
anti-DNP-PLL  antibodies  and  the  anti-BSA  antibodies  are  produced  in 
1  Paul,  W. E. and I. Green.  Unpublished observations. GREEN,  PAUL,  AND  BENACERRAF  51 
separate  cells (24). Indeed,  the  anti-DNP-PLL  antibodies  produced  by 
responder and nonresponder  guinea pigs have the same degree of PLL specific- 
ity as judged by fluorescence quenching titrations with model ligands  (25, 4). 
The alternative mechanism for the initiation of the immune response requires 
a specific processing step which is essential for the antigen to be able to stimulate 
sensitized  cells. According  to  this  hypothesis,  the formation of an antigen- 
inducer complex under the control of the PLL gene would be required for the 
stimulation of specific cells in responder guinea pigs. The binding of antigen by 
the cells would still depend upon the binding affinity  of a cellular antibody whose 
specificity  would be  identical with that of serum antibody, but no cellular 
response would result unless the antigen had been specifically processed as an 
initial step.  Indeed, this initial step may be the process through which  "im- 
munogenicity" is recognized and determinants are selected. Complex molecules 
such as normal protein antigens might be expected to offer a number of differ- 
ent sites for the operation of genetically controlled  processing steps  whereas 
amino acids homopolymers,  hapten-homopolymer conjugates,  and copolymers 
might  be  expected  to  offer but  a  single  processing site,  thus  allowing  the 
genetic control of the recognition of immunogenicity  to be clearly demonstrated. 
SUMMARY 
Genetic nonresponder guinea pigs made tolerant to BSA and then immunized 
with DNP-PLL. BSA failed to make anti-DNP-PLL antibodies.  Thus, toler- 
ance to a carrier  protein renders animals unresponsive  to the hapten which it 
bears. 
The addition in vitro of DNP-PLL or DNP-GL to lymph node cell cultures 
derived from genetic responder animals immunized with these materials led to 
a significant stimulation of 3H-thymidine incorporation into DNA. However, the 
addition of DNP-PLL or DNP-GL to lymph node cell cultures from nonre- 
sponder animals immunized with these materials failed to produce any stimula- 
tion of DNA synthesis. Furthermore, the addition of DNP-PLL to lymph node 
cell cultures from nonresponder  animals immlmiTed with DNP-PLL. BSA or 
DNP-PLL. OVA also failed to stimulate cell proliferation  in spite  of the fact 
that the lymph node cells of these  animals were producing  anti-DNP-PLL 
antibodies. 
The above facts suggest that the function of the PLL gene product is to act 
at an early crucial step in the immune mechanism to form an antigen-inducer 
complex. The specificity of this early step may be of a simple order and different 
than that of the antibody which is later produced in the immune response. 
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